Читать книгу The SAGE Encyclopedia of Stem Cell Research - Группа авторов - Страница 389

Given the prevalence of diabetes in older adults and its constant increase in children, the expanded time course of the disease, and the costs associated with it, Fradkin believes that “diabetes is a good candidate for collaboration between NIH and the Centers for Medicare and Medicaid Services (CMS). Very few of the practices Medicare pays for have been rigorously examined in [randomized clinical trials] RCTs. Given NIDDK’s track record in conducting paradigm-shifting diabetes trials in diverse populations, conducting clinical trials in the Medicare population could offer an opportunity for cost savings.” Such collaboration would work in that NIH/NIDDK and CMS would share the costs related to research and clinical care, opening a new era of collaboration that could potentially benefit diabetic patients.